Index Case of Familial Adenomatous Polyposis Revealed by Congenital Hypertrophy of the Retinal Pigment Epithelium

  1. Robert L. Holmes, DO;
  2. Saket K. Ambasht, MD; and
  3. Patrick S. Kelley, MD
  1. From Keesler Medical Center, Keesler Air Force Base, MS 39554.

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    TO THE EDITOR:

    Background: Familial adenomatous polyposis and phenotypic variants, including the Gardner syndrome, are autosomal-dominant diseases resulting from germline mutation of the adenomatous polyposis coli (APC) gene. Congenital hypertrophy of the retinal pigment epithelium (CHRPE), a benign retinal lesion without visual sequelae, is estimated to be …

    « Previous | Next Article »Table of Contents